Advances in combined radiation therapy for the management of rectal cancer.
Significant advances have been made in the use of adjuvant radiation for patients with localized rectal cancer. Recent progress in adjuvant postoperative radiation regimens relates to the integration of systemic therapy into radiation, as well as redefining the techniques and sequences for both modalities. The adjuvant radiation management approach in both North America and Europe has been shifting towards preoperative adjuvant therapy to promote sphincter-preserving surgery and to decrease acute and late toxicity. Although 5-fluorouracil-based chemotherapy in combination with radiation remains the standard adjuvant therapy for rectal cancer, the integration of novel chemotherapeutic agents and biologic modulators remains an active area of investigation.
Kachnic
Lisa A
LA
Department of Radiation Oncology, Boston Medical Center, Boston University School of Medicine, MA 02118, USA. Lisa.Kachnic@bmc.org
Shih
Helen A
HA
Willett
Christopher G
CG
D003131:Combined Modality Therapy; D006801:Humans; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*